111 related articles for article (PubMed ID: 2674453)
1. 7-oxo-PgI2 induced late appearing and long-lasting electrophysiological changes in the heart in situ of the rabbit, guinea-pig, dog and cat.
Szekeres L; Szilvássy Z; Udvary E; Végh A
J Mol Cell Cardiol; 1989 Jun; 21(6):545-54. PubMed ID: 2674453
[TBL] [Abstract][Full Text] [Related]
2. On the nature and molecular basis of prostacyclin induced late cardiac changes.
Szekeres L; Németh M; Szilvássy Z; Tósaki A; Udvary E; Végh E
Biomed Biochim Acta; 1988; 47(10-11):S6-11. PubMed ID: 3073771
[TBL] [Abstract][Full Text] [Related]
3. Short incubation with 7-oxo-prostacyclin induces long lasting prolongation of repolarisation time and effective refractory period in rabbit papillary muscle preparation.
Szekeres L; Németh M; Papp JG; Udvary E
Cardiovasc Res; 1990 Jan; 24(1):37-41. PubMed ID: 2109659
[TBL] [Abstract][Full Text] [Related]
4. 7-oxo-PGI2 induced late protective action from arrhythmias due to local myocardial ischemia.
Udvary E; Végh A; Szekeres L
Bratisl Lek Listy; 1991; 92(3-4):146-9. PubMed ID: 2029655
[TBL] [Abstract][Full Text] [Related]
5. 7-oxo-PGI2 induced late appearing and long lasting antiischaemic and antiarrhythmic action in dogs.
Végh A; Udvary E; Szekeres L; Szilvássy Z
Biomed Biochim Acta; 1988; 47(10-11):S31-4. PubMed ID: 3073767
[TBL] [Abstract][Full Text] [Related]
6. On the 7-oxo-PgI2 induced lasting protection against ouabain arrhythmias in anesthetized guinea pigs.
Szilvássy Z; Szekeres L; Udvary E; Végh A
Biomed Biochim Acta; 1988; 47(10-11):S35-8. PubMed ID: 2470357
[TBL] [Abstract][Full Text] [Related]
7. Delayed protection by 7-oxo-PGI2 against cardiac transmembrane ion shifts and early morphological changes due to ischemia and reperfusion.
Szekeres L; Bálint ZS; Karcsu S; Tósaki A
Cardioscience; 1990 Dec; 1(4):279-86. PubMed ID: 2104194
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection: endogenous protective mechanisms promoted by prostacyclin.
Szekeres L; Pataricza J; Szilvássy Z; Udvary E; Végh A
Basic Res Cardiol; 1991; 86 Suppl 3():215-21. PubMed ID: 1781766
[TBL] [Abstract][Full Text] [Related]
9. Cardiac electrophysiological effects of prostacyclin analogues, 7-oxo-PGI2 and iloprost.
Kecskemeti V
Biomed Biochim Acta; 1987; 46(8-9):S460-4. PubMed ID: 2449187
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
11. On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action.
Szekeres L; Koltai M; Pataricza J; Takáts I; Udvary E
Biomed Biochim Acta; 1984; 43(8-9):S135-42. PubMed ID: 6393960
[TBL] [Abstract][Full Text] [Related]
12. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
Szekeres L; Krassói I; Pataricza J; Udvary E
Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
Kecskeméti V; Stadler I; Körmöczy P
Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
[TBL] [Abstract][Full Text] [Related]
14. 7-oxo PGI2 dramatically increases the safety margin of digitalis.
Szilvássy Z; Szekeres L; Udvary E; Karcsu S; Végh A
Bratisl Lek Listy; 1991; 92(3-4):134-7. PubMed ID: 2029654
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
[TBL] [Abstract][Full Text] [Related]
16. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
[TBL] [Abstract][Full Text] [Related]
17. Release of 6-keto-PGF1 alpha and thromboxane B2 in late appearing cardioprotection induced by the stable PGI analogue: 7-OXO-PGI.
Szekeres L; Tósaki A
Mol Cell Biochem; 1993 Feb; 119(1-2):129-32. PubMed ID: 8455575
[TBL] [Abstract][Full Text] [Related]
18. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
19. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
Omini C; Moncada S; Vane JR
Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
[TBL] [Abstract][Full Text] [Related]
20. On the 7-oxo-PGI2 induced late appearing long-lasting cytoprotective effect.
Szekeres L; Bálint Z; Karcsu S; Tósaki A; Udvary E
Prog Clin Biol Res; 1989; 301():143-7. PubMed ID: 2508098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
